Discovery of isoindoline and tetrahydroisoquinoline derivatives as potent, selective PPARδ agonists
Luckhurst, C.A., Stein, L.A., Furber, M., Webb, N., Ratcliffe, M.J., Allenby, G., Botterell, S., Tomlinson, W., Martin, B., Walding, A.(2011) Bioorg Med Chem Lett 21: 492-496
- PubMed: 21094606 
- DOI: https://doi.org/10.1016/j.bmcl.2010.10.117
- Primary Citation of Related Structures:  
3OZ0 - PubMed Abstract: 
Small molecule isoindoline and tetrahydroisoquinoline derivatives have been identified as selective agonists of human peroxisome proliferator-activated receptor δ (PPARδ. Compound 18 demonstrated efficacy in a biomarker for increased fatty acid oxidation, with upregulation of pyruvate dehydrogenase kinase, isozyme 4 (PDK4) in human primary myotubes.
Organizational Affiliation: 
Medicinal Chemistry, AstraZeneca R&D Charnwood, Loughborough, Leicestershire LE11 5RH, UK. chris.luckhurst@astrazeneca.com